99 related articles for article (PubMed ID: 1548692)
21. Isolation and characterization of Salmonella enterica Weltevreden cytotoxin.
Singh Y; Sharma VD
Indian J Exp Biol; 1998 Mar; 36(3):298-303. PubMed ID: 9754063
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin.
Popoff MR
Infect Immun; 1987 Jan; 55(1):35-43. PubMed ID: 3793234
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
24. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
[TBL] [Abstract][Full Text] [Related]
25. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography.
Miyake M; Utsuno E; Noda M
Anal Biochem; 2000 Jun; 281(2):202-8. PubMed ID: 10870836
[TBL] [Abstract][Full Text] [Related]
26. Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effects.
Teichert M; Tatge H; Schoentaube J; Just I; Gerhard R
Infect Immun; 2006 Oct; 74(10):6006-10. PubMed ID: 16988280
[TBL] [Abstract][Full Text] [Related]
27. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
Matsuda M; Ozutsumi K; Du PY; Sugimoto N
Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Clostridium difficile toxin A and B by 1,2-cyclohexanedione modification of an arginine residue.
Balfanz J; Rautenberg P
Biochem Biophys Res Commun; 1989 Dec; 165(3):1364-70. PubMed ID: 2610698
[TBL] [Abstract][Full Text] [Related]
29. Binding of Clostridium difficile toxin A to human milk secretory component.
Dallas SD; Rolfe RD
J Med Microbiol; 1998 Oct; 47(10):879-88. PubMed ID: 9788811
[TBL] [Abstract][Full Text] [Related]
30. [Yield of detection of Clostridium difficile toxin versus stool culture in the study of nosocomial diarrhea].
Rabasa M; Aguado JM; Lizasoaín M; Pedraza MA; Arribas P; Lumbreras C; Otero JR; Noriega AR
Enferm Infecc Microbiol Clin; 1993 Nov; 11(9):479-81. PubMed ID: 8305554
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning and expression of Clostridium difficile toxin A in Escherichia coli K12.
Wren BW; Clayton CL; Mullany PP; Tabaqchali S
FEBS Lett; 1987 Dec; 225(1-2):82-6. PubMed ID: 2961615
[TBL] [Abstract][Full Text] [Related]
32. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
Torres JF; Monath TP
J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile toxin A induces a specific antisecretory factor which protects against intestinal mucosal damage.
Torres J; Jennische E; Lange S; Lönnroth I
Gut; 1991 Jul; 32(7):791-5. PubMed ID: 1855687
[TBL] [Abstract][Full Text] [Related]
34. Identification of a CHO cell-elongating factor produced by Vibrio cholerae O1.
McCardell BA; Kothary MH; Hall RH; Sathyamoorthy V
Microb Pathog; 2000 Jul; 29(1):1-8. PubMed ID: 10873485
[TBL] [Abstract][Full Text] [Related]
35. A simple 3-step algorithm for improved laboratory detection of Clostridium difficile toxin without the need for tissue culture cytotoxicity neutralization assays.
Sharp SE; Ivie WM; Buckles MR; Coover DM; Pohl JC; Hatcher PA
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):344-6. PubMed ID: 19376666
[TBL] [Abstract][Full Text] [Related]
36. Detection of variant toxin A without hemagglutination activity of Clostridium difficile and analysis of its biochemical and biological characteristics.
Kamiya S; Meng XQ; Nakamura S; Borriello SP
Jpn J Med Sci Biol; 1990 Dec; 43(6):246-7. PubMed ID: 2101141
[No Abstract] [Full Text] [Related]
37. [Using the real-time PCR assay to establish TaqMan-MGB probe for rapid identification of Clostridium difficile and its toxin].
Shao D; Ji N; Liang G; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):576-80. PubMed ID: 25059372
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection.
Ruby R; Magdesian KG; Kass PH
J Am Vet Med Assoc; 2009 Mar; 234(6):777-84. PubMed ID: 19284345
[TBL] [Abstract][Full Text] [Related]
39. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits.
Ketley JM; Mitchell TJ; Candy DC; Burdon DW; Stephen J
J Med Microbiol; 1987 Aug; 24(1):41-52. PubMed ID: 3612743
[TBL] [Abstract][Full Text] [Related]
40. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.
Ryd M; Alfredsson H; Blomberg L; Andersson A; Lindberg AA
FEBS Lett; 1989 Dec; 258(2):320-2. PubMed ID: 2689221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
